Stockreport

Suvannavejh: It has been a remarkable comeback for biotech [CNBC]

Mizuho Financial Group, Inc. Sponosred ADR (Japan)  (MFG) 
US:NYSE Investor Relations: mizuho-fg.com/investors/index.html
PDF Graig Suvannavejh, Biotech & Biopharma Analyst at Mizuho Securities, says biotech's surge is driven by strong M&A, innovation, capital access, and clearer FDA dynamics, [Read more]